Heart and liver health study for people with overweight
Part of Hormones & metabolism clinical trials.
This study tests a new medicine called survodutide to see if it can improve heart function and structure in people who are overweight and have fatty liver disease. It may help reduce risks related to heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have a body mass index (BMI) of 27 or higher.
- You must have fatty liver disease, confirmed by imaging or a liver biopsy.
- You must not have taken weight-loss medications in the past 3 months.
- You must not have a history of heart failure or severe kidney problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational medicine called survodutide to help adults with overweight or obesity lose weight. If you have tried to lose weight before with diet but haven't had lasting success, you may be able to join.
This trial compares two different versions of an injected study drug (survodutide) to see how they are absorbed by the body. It is open to healthy people and people with overweight or obesity, and it may help researchers find a better way to deliver this treatment.
This study looks at liver fat and how to manage it in people with obesity. It may help find better ways to treat fatty liver disease.
This trial tests new medicines for adults with fatty liver disease (MASLD) that has already caused some liver scarring. It aims to see if these drugs can help prevent the liver disease from getting worse.
This study tests an investigational drug called survodutide to see if it helps women who are overweight or obese and going through or finished menopause lose weight. If you qualify, you may receive the study drug or a placebo, and the study will track your weight loss over time.
This trial tests whether an experimental drug (LY3437943) can help people with obesity or overweight lose weight. It compares the drug to a placebo (inactive shot), and you must be willing to give yourself daily injections.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.